tiprankstipranks
Cognition Therapeutics (CGTX)
NASDAQ:CGTX
US Market
CGTX
Cognition Therapeutics
RESEARCH TOOLSreports
Want to see CGTX full AI Analyst Report?

Cognition Therapeutics (CGTX) Income Statement

634 Followers

Cognition Therapeutics Income Statement

Last quarter (Q1 2026), Cognition Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Cognition Therapeutics's net income was $-4.57M. See Cognition Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ -252.00K$ -235.00K$ 0.00
Operating Expenses
$ 47.80M$ 53.97M$ 50.72M$ 43.32M$ 28.60M
Depreciation and Amortization
$ 228.00K$ 266.00K$ 252.00K$ 235.00K$ 93.00K
EBITDA
$ -23.25M$ -33.68M$ -25.51M$ -21.13M$ -10.73M
Operating Income
$ -47.80M$ -53.97M$ -50.72M$ -43.55M$ -28.60M
Other Income/Expenses
$ 24.31M$ 20.00M$ 24.94M$ 22.15M$ 16.88M
Pretax Income
$ -23.49M$ -33.97M$ -25.79M$ -21.40M$ -11.72M
Net Income
$ -23.49M$ -33.97M$ -25.79M$ 757.00K$ -11.72M
Per Share Metrics
Basic EPS
$ -0.32$ -0.85$ -0.86$ -0.74$ -0.73
Diluted EPS
$ -0.32$ -0.85$ -0.86$ -0.74$ -0.73
Weighted Average Shares Outstanding
 72.77M 39.73M 29.99M 28.99M 22.23M
Weighted Average Shares Outstanding (Diluted)
 72.77M 39.73M 30.03M 28.99M 22.23M
Currency in USD

Cognition Therapeutics Earnings and Revenue History